Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The zebrafish model of tuberculosis - no lungs needed

G. Bouz, N. Al Hasawi,

. 2018 ; 44 (6) : 779-792. [pub] 20190121

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027887

Tuberculosis is still a global health burden. It is caused by Mycobacterium tuberculosis which afflicts around one third of the world's population and costs around 1.3 million people their lives every year. Bacillus Calmette-Guerin vaccine is inefficient to prevent overt infection. Additionally, the lengthy inconvenient course of treatment, along with the raising issue of antimicrobial resistance, result in incomplete eradication of this infectious disease. The lack of proper animal models that replicate the latent and active courses of human tuberculosis infection remains one of the main reasons behind the poor advancement in tuberculosis research. Danio rerio, commonly known as zebrafish, is catching more attention as an animal model in tuberculosis research field. This shift is based on the histological and pathological similarities between Mycobacterium marinum infection in zebrafish and Mycobacterium tuberculosis infection in humans. Being small, cheap, transparent, and easy to handle have added further advantages to the use of zebrafish model. Besides better understanding of the pathogenesis of tuberculosis, Mycobacterium marinum infected zebrafish model is useful for evaluating novel vaccines against human tuberculosis, high throughput small molecule screening, repurposing established drugs with possible antitubercular activity, and assessing novel antituberculars for hepatotoxicity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027887
003      
CZ-PrNML
005      
20190820085911.0
007      
ta
008      
190813s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/1040841X.2018.1523132 $2 doi
035    __
$a (PubMed)30663918
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bouz, Ghada $u a Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove , Charles University , Hradec Kralove , Czech Republic.
245    14
$a The zebrafish model of tuberculosis - no lungs needed / $c G. Bouz, N. Al Hasawi,
520    9_
$a Tuberculosis is still a global health burden. It is caused by Mycobacterium tuberculosis which afflicts around one third of the world's population and costs around 1.3 million people their lives every year. Bacillus Calmette-Guerin vaccine is inefficient to prevent overt infection. Additionally, the lengthy inconvenient course of treatment, along with the raising issue of antimicrobial resistance, result in incomplete eradication of this infectious disease. The lack of proper animal models that replicate the latent and active courses of human tuberculosis infection remains one of the main reasons behind the poor advancement in tuberculosis research. Danio rerio, commonly known as zebrafish, is catching more attention as an animal model in tuberculosis research field. This shift is based on the histological and pathological similarities between Mycobacterium marinum infection in zebrafish and Mycobacterium tuberculosis infection in humans. Being small, cheap, transparent, and easy to handle have added further advantages to the use of zebrafish model. Besides better understanding of the pathogenesis of tuberculosis, Mycobacterium marinum infected zebrafish model is useful for evaluating novel vaccines against human tuberculosis, high throughput small molecule screening, repurposing established drugs with possible antitubercular activity, and assessing novel antituberculars for hepatotoxicity.
650    _2
$a zvířata $7 D000818
650    _2
$a antituberkulotika $x farmakologie $7 D000995
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a lidé $7 D006801
650    _2
$a Mycobacterium marinum $x účinky léků $x fyziologie $7 D019910
650    _2
$a Mycobacterium tuberculosis $x účinky léků $x fyziologie $7 D009169
650    _2
$a tuberkulóza $x farmakoterapie $x mikrobiologie $7 D014376
650    12
$a dánio pruhované $x mikrobiologie $7 D015027
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Al Hasawi, Nada $u b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Kuwait University , Kuwait , State of Kuwait.
773    0_
$w MED00007171 $t Critical reviews in microbiology $x 1549-7828 $g Roč. 44, č. 6 (2018), s. 779-792
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30663918 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190820090146 $b ABA008
999    __
$a ok $b bmc $g 1433036 $s 1066347
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 44 $c 6 $d 779-792 $e 20190121 $i 1549-7828 $m Critical reviews in microbiology $n Crit Rev Microbiol $x MED00007171
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...